Australia allows phase-in for updated GMP guide for overseas manufacturers
This article was originally published in SRA
Executive Summary
Australia's Therapeutic Goods Administration has set a deadline of 15 August for overseas manufacturers of medicinal products, including active pharmaceutical ingredients, to implement its updated guidance on good manufacturing practice1,2.